Today, the U.S. Food and Drug Administration (FDA) is announcing a public workshop entitled “Evolving Role of Artificial Intelligence in Radiological Imaging,” will be held February 25-26, 2020. This workshop is an opportunity for stakeholders to provide feedback to the FDA on the following topics:
- Emerging applications of Artificial Intelligence (AI) in radiological imaging, including devices intended to automate the diagnostic radiology workflow and enable guided image acquisition;
- Benefits and risks associated with using AI in radiological imaging; and
- Best practices for the validation of AI-automated radiological imaging software and image acquisition devices to assess safety and effectiveness.
No hay comentarios:
Publicar un comentario